NVCT · smart money activity
Who's buying Nuvectis Pharma, Inc.?
Perceptive Advisors: new position: 1.00M sh (~$18.4M, 0.3% of book).
Smart money score27#164 of 372 stocks
Latest filingAug 14, 2026
Independent buyers1
Signal sources13F
Signals against0
NVCT insider buying, 13F and 13D filings
-
Perceptive Advisors: New position: 1.00M sh (~$18.4M, 0.3% of book)13F for the quarter ended 2026-06-30. Filed 2026-08-14.
Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.